Squarepoint
STRO icon

Squarepoint’s Sutro Biopharma STRO Stock Holding History

Squarepoint’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,971
Closed -$172K – 5479
2024
Q3 		$172K Buy
4,971
+1,052
+27% +$41.2K ﹤0.01% 3741
2024
Q2 		$115K Buy
+3,919
New +$155K ﹤0.01% 3770
2024
Q1 		– Sell
-1,390
Closed -$59.6K – 4590
2023
Q4 		$59.6K Buy
+1,390
New +$44.1K ﹤0.01% 3832
2023
Q2 		– Sell
-1,295
Closed -$59.8K – 3996
2023
Q1 		$59.8K Buy
+1,295
New +$82.2K ﹤0.01% 3033
2022
Q3 		– Sell
-3,404
Closed -$177K – 3418
2022
Q2 		$177K Sell
3,404
-768
-18% -$42.9K ﹤0.01% 2509
2022
Q1 		$343K Buy
4,172
+392
+10% +$37.3K ﹤0.01% 2199
2021
Q4 		$562K Buy
3,780
+2,657
+237% +$476K ﹤0.01% 2066
2021
Q3 		$212K Sell
1,123
-2,365
-68% -$450K ﹤0.01% 2453
2021
Q2 		$648K Buy
+3,488
New +$683K ﹤0.01% 1956
2020
Q4 		– Sell
-2,866
Closed -$288K – 3248
2020
Q3 		$288K Sell
2,866
-132
-4% -$12.5K ﹤0.01% 1830
2020
Q2 		$233K Sell
2,998
-939
-24% -$90.1K ﹤0.01% 1751
2020
Q1 		$402K Buy
3,937
+1,155
+42% +$121K 0.01% 1153
2019
Q4 		$306K Buy
2,782
+687
+33% +$70.8K ﹤0.01% 2028
2019
Q3 		$190K Buy
2,095
+845
+68% +$85.3K ﹤0.01% 2096
2019
Q2 		$142K Buy
+1,250
New +$138K ﹤0.01% 2169

Other funds holding STRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Squarepoint's STRO Position: Q4 2024 in Review

Squarepoint sold out of Sutro Biopharma (STRO) in Q4 2024, closing a stake of 4,971 shares — an estimated $172K sold.

Squarepoint first reported a position in STRO in Q2 2019 and held it in 15 quarters. The position peaked at $648K in Q2 2021. 122 funds tracked by Wall St. Rank hold STRO as of Q4 2024.

  • Squarepoint reported no remaining Sutro Biopharma position as of Q4 2024 after selling out during the quarter.
  • Squarepoint sold 4,971 Sutro Biopharma shares in Q4 2024, an estimated $172K.
  • Squarepoint first reported a position in Sutro Biopharma in Q2 2019 and held it in 15 quarters.
  • Squarepoint's Sutro Biopharma position peaked at $648K in Q2 2021.
  • 122 funds tracked by Wall St. Rank held Sutro Biopharma as of Q4 2024.

Based on Squarepoint's 13F filing for Q4 2024, filed 14 Feb 2025.